Metaanalyse: 1 % fortrydelse efter kønsoperation, men de inkluderede studier havde kort opfølgning og stort frafald

Fortrydelse efter kønsbekræftende operation: Et systematisk review og metaanalyse af forekomst

Authors
Valeria P. Bustos, Samyd S. Bustos, Andres Mascaro, Gabriel Del Corral, Antonio J. Forte, Pedro Ciudad, Esther A. Kim, Howard N. Langstein, Oscar J. Manrique
Journal
Plastic and Reconstructive Surgery Global Open
Year
2021

Summary

This review combined 27 studies of nearly 8,000 people who had gender surgery and estimated that about 1% regretted it. The authors concluded regret is extremely rare and credited better screening of patients. The 1% figure is now widely quoted. But the authors themselves say the evidence underneath is weak: most studies were rated poor or fair, almost none used tested ways of measuring regret, and results varied a lot between studies. Critics point out that people were often followed for only one or two years, while regret typically shows up after about eight years. Many people were lost track of (36% in the largest study), and some numbers were copied wrongly. Most people studied were adults treated under older, stricter rules. The 1% is best seen as a minimum drawn from incomplete data, not a reliable regret rate for today's patients.

Key findings

  • Gennemgangen inkluderede 27 studier med 7.928 kirurgipatienter fra 14 lande; 67 % havde fået mand-til-kvinde- og 33 % kvinde-til-mand-kirurgi, og kun én patient var registreret som ikke-binær.
  • Samlet set fortrød omkring 1 % af patienterne operationen (sandsynligvis mellem under 1 % og 2 %), men resultaterne varierede meget mellem studierne; 77 personer i alt rapporterede fortrydelse.
  • Fortrydelse var under 1 % efter kvinde-til-mand-kirurgi og brystfjernelse, 1 % efter mand-til-kvinde-kirurgi og 2 % efter kirurgi til at skabe en vagina.
  • De mest almindelige årsager til fortrydelse var vanskeligheder med at blive accepteret af familie og samfund i den nye kønsrolle, efterfulgt af dårlige kirurgiske eller fysiske resultater.
  • Næsten alle studier brugte hjemmelavede spørgsmål eller interviews, de fleste blev vurderet som af dårlig eller rimelig kvalitet, og opfølgningen varierede fra under 1 år til 9 år.
  • Der var tegn på, at studier med lav fortrydelse oftere blev offentliggjort; justering for dette sænkede skønnet fra 1 % til 0,5 %.
  • En rettelse i 2022 rettede tabeller og figurer, efter at forfatterne kørte gennemgangen igen, og offentliggjorte breve (Expósito-Campos & D'Angelo 2021; Bewley 2022) udfordrede metoderne og konklusionerne.

Abstract

Background: There is an unknown percentage of transgender and gender non-confirming individuals who undergo gender-affirmation surgeries (GAS) that experiences regret. Regret could lead to physical and mental morbidity and questions the appropriateness of these procedures in selected patients. The aim of this study was to evaluate the prevalence of regret in transgender individuals who underwent GAS and evaluate associated factors.

Methods: A systematic review of several databases was conducted. Random-effects meta-analysis, meta-regression, and subgroup and sensitivity analyses were performed.

Results: A total of 27 studies, pooling 7928 transgender patients who underwent any type of GAS, were included. The pooled prevalence of regret after GAS was 1% (95% CI <1%-2%). Overall, 33% underwent transmasculine procedures and 67% transfemenine procedures. The prevalence of regret among patients undergoing transmasculine and transfemenine surgeries was <1% (IC <1%-<1%) and 1% (CI <1%-2%), respectively. A total of 77 patients regretted having had GAS. Twenty-eight had minor and 34 had major regret based on Pfäfflin's regret classification. The majority had clear regret based on Kuiper and Cohen-Kettenis classification.

Conclusions: Based on this review, there is an extremely low prevalence of regret in transgender patients after GAS. We believe this study corroborates the improvements made in regard to selection criteria for GAS. However, there is high subjectivity in the assessment of regret and lack of standardized questionnaires, which highlight the importance of developing validated questionnaires in this population.

Conclusion

Based on this review, there is an extremely low prevalence of regret in transgender patients after GAS. We believe this study corroborates the improvements made in regard to selection criteria for GAS. However, there is high subjectivity in the assessment of regret and lack of standardized questionnaires, which highlight the importance of developing validated questionnaires in this population.